Arix Bioscience logo

Arix Bioscience

Europe, England, United Kingdom, London

Description

Arix Bioscience is a global venture capital company that invests in breakthrough biotechnology companies.

Investor Profile

Arix Bioscience has made 31 investments, with 0 in the past 12 months and 45% as lead.

Stage Focus

  • Series B (32%)
  • Series A (26%)
  • Series C (19%)
  • Post Ipo Equity (13%)
  • Series Unknown (3%)
  • Series F (3%)
  • Seed (3%)

Country Focus

  • United States (61%)
  • United Kingdom (16%)
  • France (6%)
  • Israel (6%)
  • Ireland (3%)
  • Canada (3%)
  • Denmark (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Therapeutics
  • Biopharma
  • Genetics
  • Oncology
  • Medical Device
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Arix Bioscience frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 9
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 5
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 4
CA
North America, Massachusetts, United States, Boston
Co-Investments: 4
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 4
Lundbeckfonden Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 6
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 4
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 4

What are some of recent deals done by Arix Bioscience?

Evommune

Palo Alto, California, United States

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

BiotechnologyHealth CareLife Science
Series BApr 26, 2023
Amount Raised: $50,000,000
Harpoon Therapeutics

South San Francisco, California, United States

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityMar 27, 2023
Amount Raised: $25,000,000
Ensoma

Boston, Massachusetts, United States

Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.

BiotechnologyGeneticsLife ScienceMedicalOncologyTherapeutics
Series BJan 5, 2023
Amount Raised: $85,000,000
Disc Medicine

Watertown, Massachusetts, United States

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Post Ipo EquityAug 10, 2022
Amount Raised: $53,500,000
Sorriso Pharmaceuticals

San Diego, California, United States

Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.

BiotechnologyPharmaceuticalTherapeutics
Series ADec 22, 2021
Amount Raised: $31,000,000
Depixus

Paris, Ile-de-France, France

Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.

BiotechnologyGeneticsMedical
Series ADec 15, 2021
Amount Raised: $34,547,891
Disc Medicine

Watertown, Massachusetts, United States

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Post Ipo EquitySep 2, 2021
Amount Raised: $90,000,000
Artios Pharma

Cambridge, Cambridgeshire, United Kingdom

Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies.

BiopharmaBiotechnologyMedical Device
Series CJul 27, 2021
Amount Raised: $152,701,427
Pyxis Oncology

Boston, Massachusetts, United States

Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.

BiotechnologyHealth CareOncologyPharmaceutical
Series BMar 30, 2021
Amount Raised: $152,000,000
Aura Biosciences

Cambridge, Massachusetts, United States

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

BiotechnologyHealth CarePharmaceutical
Series UnknownMar 22, 2021
Amount Raised: $80,000,000